Security key
293602405
Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC)
CUSIP: 293602405
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 499,209
- Total 13F value
- $253,033
- Share change
- +199,462
- SEC-reported price per share
- $0.51
- Number of holders
- 10
- Value change
- +$94,982
- Number of buys
- 7
- Number of sells
- 3
- Shares outstanding
- 19,603,857
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
10
Top holders
10
ENSC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Ensysce Biosciences, Inc. SEC filings
Ensysce Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 293602405
Recent filing periods:
Ownership snapshot
Top reported holders of ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
A. Lorne Weil
Comparable rows
9/15
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 1.2%
6 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 1.2%.
9 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
SABBY MANAGEMENT, LLC
1.2%
GEODE CAPITAL MANAGEMENT, LLC
0.09%
VANGUARD GROUP INC
0.09%
UBS Group AG
0.06%
RENAISSANCE TECHNOLOGIES LLC
0.05%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
Company
|
1.2%
|
$182,184
230,554 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.09%
|
$14,474
18,318 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.09%
|
$14,362
18,175 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
0.06%
|
$9,962
12,610 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.05%
|
$8,000
10,554 shares
|
— | 31 Mar 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.04%
|
$6,451
8,166 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
499,209
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
9
Q2 2024 holders
10
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend